Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 010.31 M10.63 M11.45 M00 22.08 M Research & development —————— — Operating income 151.83 M228.17 M170.41 M171.72 M162.54 M222.59 M 727.26 M Non-Operating Income, Total 1.72 M-7.96 M394 K958 K488 K883 K 2.72 M Interest expense, net of interest capitalized 3.11 M5.72 M1.28 M1.49 M1.88 M5.75 M 10.4 M Non-Operating Income, excl. Interest Expenses -1.39 M-13.69 M-885 K-530 K-1.4 M-4.87 M -7.68 M Unusual income/expense —————— — Pretax income 37.92 M91.36 M47.16 M48.37 M42.66 M87.23 M 225.41 M Equity in earnings —————— — Taxes 6.29 M16.17 M4.79 M9.3 M7.19 M14.17 M 35.46 M Non-controlling/minority interest 199 K237 K213 K266 K299 K151 K 929 K After tax other income/expense —————— — Net income before discontinued operations 31.43 M74.96 M42.15 M38.8 M35.17 M72.91 M 189.02 M Discontinued operations —————— — Net income 31.43 M74.96 M42.15 M38.8 M35.17 M72.91 M 189.02 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 31.3 M74.69 M42 M38.65 M35.12 M72.84 M 188.6 M Basic earnings per share (Basic EPS) 1.293.161.831.691.573.37 8.46 Diluted earnings per share (Diluted EPS) 1.293.141.811.691.573.35 8.42 Average basic shares outstanding 24.22 M23.66 M23.01 M23.4 M22.31 M21.61 M — Diluted shares outstanding 24.28 M23.78 M23.14 M23.52 M22.38 M21.72 M — EBITDA 195.41 M254.68 M182.78 M220.81 M166.38 M226.69 M 796.66 M EBIT 151.83 M228.17 M170.41 M171.72 M155.66 M216.64 M 714.44 M Cost of revenue 12.03 M35.27 M9.28 M-6.43 M3.23 M45.62 M 51.69 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 12.24 M12.86 M12.37 M49.09 M10.71 M10.05 M 82.22 M